Roche-HIV.com

Search this site

Roche in HIV

Understanding HIV

About HIV

Management issues

Guidelines (HIV and HCV)

Pharmaceutical products

Commitment to research

Healthcare professionals


Roche events		Archives

	10th European AIDS Conference (EACS), Dublin, Ireland, 17-20 November 2005
	1. What should be the standard of care for triple-class-experienced patients?, Professor Julio Montaner
	2. Turning the page to a greater acceptance of enfuvirtide-based therapy, Professor Christine Katlama
	3. Documenting the utility of boosted Invirase, Professor Sharon Walmsley
	4. A new chapter in the clinical use of boosted Invirase, Dr Mike Youle
	5. Expanding the library of drug interaction data for Invirase/r, Dr Marta Boffito

	3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005
	ABSTRACT BOOK: INDIVIDUALITY - An interactive case-study symposium exploring optimal treatments for individual patients, Roche Satellite Symposium
	1. Knowing your options - Invirase 500: a new option for your first PI, Dr Mike Youle
	2. Changing your choices - Invirase 500: excellent tolerability when you need to switch, Professor Michael Saag
	3. Achieving your goals - Invirase 500: the preferred partner in double boosting, Professor Calvin Cohen
	4. Setting your standards: Achieve more with FUZEON Professor Fran�ois Raffi
	5. Planning your future: Make the most of future options with FUZEON, Professor David Cooper
	6. Focusing on FUZEON: Act to get the best results, Professor Calvin Cohen

	7th International Congress on Drug Therapy in HIV Infection (HIV7), Glasgow, November 2004
	ABSTRACT BOOK: The ART of INNOVATION - Roche Satellite Symposium
	1. POWER: Building up steam for a maximal virological response, Professor Sharon Walmsley.
	2. STRENGTH: Supporting treatment-experienced patients with double-boosted regimens, Dr Anton Pozniak
	3. VISION: Picturing long-term success in treatment-experienced patients, Dr Calvin J. Cohen
	4. EXPLORATION: Beating a new path to improved antiretroviral tolerability, Professor David A Cooper

	10th British HIV Association Autumn Conference, 8-9 November 2004
	ABSTRACT BOOK: The Changing Landscape of Antiretroviral Therapy - Roche Satellite Symposium
	1. Attaining New Heights: 24-week data from the STACCATO trial induction phase, Professor Joep Lange
	2. Firm foundations for long-term durability: The TORO study - 96-week results, Professor Francois Raffi
	3. Viewing from a different angle: FUZEON - a new treatment approach to NRTI-sparing regimens in treatment-experienced patients, Professor David Cooper

	XV International AIDS Conference (IAC) Bangkok, Thailand, 11-16 July 2004
	ABSTRACT BOOK: Harmony in ART - Roche Satellite Symposium
	1. Flying with successful ART: A history of commitment in HIV, Professor Praphan Phanuphak
	2. The right frame for success: A simple new Viracept formulation for improved safety and convenience, Dr Margaret Johnson
	3. Pulling together for superior control: The power of double boosting with Invirase/r, Professor Sharon Walmsley
	4. Pushing horizons, maintaining success: Durable efficacy and safety with FUZEON, Dr Calvin J Cohen
	5. Going the distance � a new flight plan: Developing kinder treatment regimens for patients, Professor David A Cooper

All information contained in this website is generated and maintained by F. Hoffmann-La Roche, Ltd, Basel, Switzerland. This site is intended for use by physicians only. This site is not intended for residents of the United States of America.

Contact webmaster